Intellia Therapeutics Presents Progress in Lead In Vivo Program at Cold Spring Harbor Laboratory’s Fourth Meeting on Genome Engineering: The CRISPR-Cas Revolution
pharmaceutical investing Intellia Therapeutics Announces Fourth Quarter and Full Year 2017 Financial Results
Intellia Therapeutics Announces Publication in Cell Reports of Preclinical Data Demonstrating Effective CRISPR/Cas9 Genome Editing
Stardust Metal Uncovers Large, Never-Drilled Ultramafic Target Adjacent to High-Grade Kerr Addison in Kirkland Lake
E-Power Resources Appoints New CEO and Expands Advisory Teams; Focus on Agressive Strategy for Tetepisca Graphite Project
Standard Uranium Receives Drill Permits and Initiates Ground Gravity Survey on the Corvo Uranium Project
